• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯环利定对大鼠的位置厌恶条件反射:耐受性的发展及药理学拮抗作用

Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism.

作者信息

Iwamoto E T

出版信息

Alcohol Drug Res. 1985;6(4):265-76.

PMID:2418852
Abstract

The pharmacologic properties of phencyclidine were assessed in adult, male rats using a three-chambered, place-conditioning apparatus. Phencyclidine hydrochloride (PCP), at doses of 0.5 to 4 mg/kg, produced a dose-related place-aversion after three drug/environment pairings. During the place-conditioning procedure, 4 mg/kg of PCP significantly increased spontaneous locomotor activity compared to saline-control. Tolerance to PCP-induced place-aversion developed after four daily administrations of 4 mg/kg of PCP. d-Butaclamol, 0.4 mg/kg, given 1 min before each of the three conditioning-doses of PCP decreased the development of the place-aversion induced by PCP. 1-Butaclamol was without significant effect. Spiroperidol, 0.06 mg/kg, completely blocked the development of PCP place-aversion. Spiroperidol and the stereoisomers of butaclamol did not have significant place-conditioning activity when administered alone in the place-conditioning paradigm. The data suggest that PCP induces place-aversion in rats in the place-conditioning model, and that tolerance to this effect develops within 4 days. Furthermore, since d-butaclamol or spiroperidol, but not 1-butaclamol, antagonized this effect of PCP, PCP-induced place-aversion may be mediated in part by a dopaminergic mechanism.

摘要

使用三室位置条件化装置,对成年雄性大鼠的苯环利定药理特性进行了评估。盐酸苯环利定(PCP)剂量为0.5至4mg/kg,在三次药物/环境配对后产生剂量相关的位置厌恶。在位置条件化过程中,与生理盐水对照相比,4mg/kg的PCP显著增加了自发运动活性。在每日给予4mg/kg的PCP四次后,对PCP诱导的位置厌恶产生了耐受性。在每次给予PCP的三个条件剂量前1分钟给予0.4mg/kg的d-布他拉莫,可减少PCP诱导的位置厌恶的形成。l-布他拉莫无显著作用。0.06mg/kg的螺哌啶完全阻断了PCP位置厌恶的形成。在位置条件化范式中单独给药时,螺哌啶和布他拉莫的立体异构体没有显著的位置条件化活性。数据表明,在位置条件化模型中,PCP在大鼠中诱导位置厌恶,并且对这种效应的耐受性在4天内形成。此外,由于d-布他拉莫或螺哌啶(而非l-布他拉莫)拮抗了PCP的这种效应,PCP诱导的位置厌恶可能部分由多巴胺能机制介导。

相似文献

1
Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism.苯环利定对大鼠的位置厌恶条件反射:耐受性的发展及药理学拮抗作用
Alcohol Drug Res. 1985;6(4):265-76.
2
Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly.多巴胺能系统在反复给予苯环利定预处理的小鼠中对苯环利定诱导的位置偏爱行为的影响。
J Pharmacol Exp Ther. 1998 Jul;286(1):44-51.
3
Presynaptic dopaminergic activity of phencyclidine in rat caudate.苯环己哌啶在大鼠尾状核中的突触前多巴胺能活性。
J Pharmacol Exp Ther. 1984 Apr;229(1):321-32.
4
Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.美他菲,一种苯环利定受体的酰化配体:大鼠体内作用特征
J Pharmacol Exp Ther. 1986 Sep;238(3):1101-7.
5
Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning.一氧化氮合酶抑制剂L-NAME对苯环利定在味觉厌恶条件反射中潜在抑制作用的拮抗作用。
Behav Brain Res. 2005 Jun 3;161(1):60-8. doi: 10.1016/j.bbr.2005.01.008. Epub 2005 Feb 16.
6
Stimulation of serotonin1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats.刺激5-羟色胺1B受体可诱发大鼠的条件性位置厌恶,并促进可卡因位置条件反射。
Psychopharmacology (Berl). 2002 Sep;163(2):142-50. doi: 10.1007/s00213-002-1145-8. Epub 2002 Jul 17.
7
Morphine sex-dependently induced place conditioning in adult Wistar rats.吗啡在成年Wistar大鼠中诱导出性别依赖性的位置偏爱效应。
Eur J Pharmacol. 2008 Mar 17;582(1-3):78-87. doi: 10.1016/j.ejphar.2007.12.010. Epub 2007 Dec 23.
8
Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats.急性苯环利定会引发厌恶,但在大鼠的位置条件反射试验中,重复给予苯环利定会导致偏好。
Eur J Pharmacol. 1996 Dec 27;318(1):7-9. doi: 10.1016/s0014-2999(96)00875-8.
9
Continuous intravenous infusion of phencyclidine in unrestrained rats results in the rapid induction of tolerance and physical dependence.
J Pharmacol Exp Ther. 1985 Aug;234(2):415-24.
10
Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.苯环己哌啶对大鼠回避电击任务中亮度辨别能力的破坏作用及其拮抗作用
J Pharmacol Exp Ther. 1983 Jun;225(3):503-8.

引用本文的文献

1
Use and abuse of dissociative and psychedelic drugs in adolescence.青少年时期致幻剂和迷幻剂的使用与滥用。
Pharmacol Biochem Behav. 2021 Apr;203:173129. doi: 10.1016/j.pbb.2021.173129. Epub 2021 Jan 28.
2
Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulus.研究苯环利定的强化增强作用及其与尼古丁在视觉刺激下对杠杆按压行为的相互作用。
Behav Brain Res. 2015 Sep 15;291:253-259. doi: 10.1016/j.bbr.2015.05.043. Epub 2015 May 27.
3
Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats.
苯环利定对大鼠在有或无视觉刺激情况下尼古丁自我给药及复吸的行为影响。
Psychopharmacology (Berl). 2015 Aug;232(16):2877-87. doi: 10.1007/s00213-015-3923-0. Epub 2015 Apr 7.
4
Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure.氯氮平可减轻在颅内自我刺激程序中反复给予苯环己哌啶所诱导的反应抑制和任务效率的破坏。
Eur J Pharmacol. 2009 Jan 5;602(1):78-84. doi: 10.1016/j.ejphar.2008.11.001. Epub 2008 Nov 9.
5
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex.苯环利定及相关药物在伏隔核壳部和前额叶皮质的奖赏作用。
J Neurosci. 1996 May 1;16(9):3112-22. doi: 10.1523/JNEUROSCI.16-09-03112.1996.
6
Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration.
Psychopharmacology (Berl). 1993;111(4):402-8. doi: 10.1007/BF02253528.
7
Tolerance and selective cross-tolerance to the motivational effects of opioids.对阿片类药物的动机效应的耐受性和选择性交叉耐受性。
Psychopharmacology (Berl). 1988;96(1):110-5. doi: 10.1007/BF02431542.
8
SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?SCH 23390阻断药物条件性位置偏爱和位置厌恶:多巴胺受体阻断后是快感缺失(奖赏缺乏)还是冷漠(动机缺乏)?
Psychopharmacology (Berl). 1989;99(2):151-5. doi: 10.1007/BF00442800.
9
Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists.5-羟色胺3受体拮抗剂对药物条件性位置厌恶习得的阻断作用
Psychopharmacology (Berl). 1990;100(4):459-63. doi: 10.1007/BF02243996.